Eicosapentaenoic acid monoglycerides

N/A

Report date: 2022/11/27 23:58:47
NME

Base Information

Drug NameEicosapentaenoic acid monoglycerides
Drug Alias NameMAG-EPA
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionLipopolysaccharide (LPS) inhibitors
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesScf Pharma
China Registration ClassN/A

Develop Information

Active CompaniesScf Pharma
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A